Bank of New Hampshire Has $3.36 Million Stock Holdings in Cardinal Health, Inc. $CAH

Key Points

• Bank of New Hampshire reduced its stake in Cardinal Health, Inc. by 16.8% during the second quarter, holding 20,008 shares worth approximately $3.36 million after selling 4,042 shares.
• Cardinal Health recently reported Q1 earnings of $2.08 per share, exceeding expectations, but its revenue of $60.16 billion fell short of the consensus estimate.
• The company declared a quarterly dividend of $0.5107 per share, representing a yield of 1.4%, with the payment scheduled for October 15th to shareholders of record as of October 1st.

Bank of New Hampshire decreased its position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 16.8% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 20,008 shares of the company's stock after selling 4,042 shares during the period. Bank of New Hampshire's holdings in Cardinal Health were worth $3,361,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of the company. MassMutual Private Wealth & Trust FSB boosted its position in Cardinal Health by 3.6% during the second quarter. MassMutual Private Wealth & Trust FSB now owns 1,767 shares of the company's stock valued at $297,000 after purchasing an additional 62 shares during the last quarter. Pinnacle Bancorp Inc. lifted its position in shares of Cardinal Health by 11.2% in the first quarter. Pinnacle Bancorp Inc. now owns 767 shares of the company's stock worth $106,000 after buying an additional 77 shares during the last quarter. Thurston Springer Miller Herd & Titak Inc. lifted its position in shares of Cardinal Health by 7.9% in the second quarter. Thurston Springer Miller Herd & Titak Inc. now owns 1,074 shares of the company's stock worth $181,000 after buying an additional 79 shares during the last quarter. Applied Finance Capital Management LLC lifted its position in shares of Cardinal Health by 1.4% in the first quarter. Applied Finance Capital Management LLC now owns 6,049 shares of the company's stock worth $833,000 after buying an additional 85 shares during the last quarter. Finally, CSS LLC IL lifted its position in shares of Cardinal Health by 0.8% in the fourth quarter. CSS LLC IL now owns 11,190 shares of the company's stock worth $1,323,000 after buying an additional 90 shares during the last quarter. Institutional investors and hedge funds own 87.17% of the company's stock.

Cardinal Health Stock Down 1.2%

Shares of CAH stock opened at $150.45 on Tuesday. The firm has a 50 day moving average price of $154.16 and a two-hundred day moving average price of $148.08. The company has a market capitalization of $35.93 billion, a PE ratio of 23.33, a price-to-earnings-growth ratio of 1.29 and a beta of 0.73. Cardinal Health, Inc. has a 12-month low of $106.54 and a 12-month high of $168.44.

Cardinal Health (NYSE:CAH - Get Free Report) last issued its quarterly earnings data on Tuesday, August 12th. The company reported $2.08 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.03 by $0.05. The firm had revenue of $60.16 billion during the quarter, compared to the consensus estimate of $60.91 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The business's revenue for the quarter was up .5% compared to the same quarter last year. During the same period last year, the business posted $1.84 earnings per share. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. As a group, research analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be given a $0.5107 dividend. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.4%. The ex-dividend date is Wednesday, October 1st. Cardinal Health's payout ratio is presently 31.63%.

Insider Buying and Selling

In other news, insider Ola M. Snow sold 28,151 shares of Cardinal Health stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $148.94, for a total value of $4,192,809.94. Following the completion of the sale, the insider directly owned 15,431 shares in the company, valued at approximately $2,298,293.14. The trade was a 64.59% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Michelle D. Greene sold 13,500 shares of Cardinal Health stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total transaction of $2,009,070.00. Following the completion of the sale, the insider owned 14,976 shares of the company's stock, valued at approximately $2,228,728.32. The trade was a 47.41% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 271,676 shares of company stock valued at $40,489,525 in the last quarter. Corporate insiders own 0.09% of the company's stock.

Analyst Ratings Changes

A number of analysts have weighed in on the company. Morgan Stanley reaffirmed an "overweight" rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Argus set a $189.00 price objective on Cardinal Health in a research report on Friday, August 22nd. Bank of America boosted their price objective on Cardinal Health from $165.00 to $170.00 and gave the stock a "buy" rating in a research report on Tuesday, June 10th. Jefferies Financial Group set a $150.00 price objective on Cardinal Health in a research report on Tuesday, August 12th. Finally, Wells Fargo & Company reissued an "overweight" rating and set a $185.00 price objective (up previously from $183.00) on shares of Cardinal Health in a research report on Wednesday, August 13th. Eleven analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. Based on data from MarketBeat, Cardinal Health has a consensus rating of "Moderate Buy" and an average target price of $165.93.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.